Skip to main content
Equibles

Ikarian Capital, LLC

Position in LPCN — Lipocine Inc.

CIK 1778253 DALLAS, TX
Back to LPCN Full portfolio

Position in LPCN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,301,903
-$2,761,459 QoQ
Shares Held
508,556
0.0% QoQ
Ownership
6.17%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#2
of 36 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LPCN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names. LPCN ranks #65 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 328,635 $43,793,900
2 KOD
Kodiak Sciences Inc.
 1,059,730 $41,287,080
3 ALMS
Alumis Inc.
 870,548 $24,497,220
4 PRAX
Praxis Precision Medicines, Inc.
 72,842 $24,386,773
5 PCVX
Vaxcyte, Inc.
 388,682 $22,594,084
6 CLDX
Celldex Therapeutics, Inc.
 478,500 $17,804,985
7 RCUS
Arcus Biosciences, Inc.
 504,559 $15,555,553
8 RLMD
Relmada Therapeutics, Inc.
 2,148,359 $14,866,644

All Filings in LPCN

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,301,903 508,556
2026-03-31 $4,063,362 508,556
2025-12-31 $1,602,322 199,542